“England Leads Hepatitis C Elimination Push While U.S. Lags, Experts Say” — what this page in the network covers. England and several other nations are on track to eliminate hepatitis C as a public health threat by 2030, but the United States is falling behind despite having the tools to do so, according to public health experts. has highly effective antiviral medications that can cure hepatitis C in most patients, yet barriers such as high drug costs, limited screening, and fragmented care prevent widespread access. Experts argue that without a coordinated national strategy and sustained investment, the U.S.
will continue to see preventable liver disease, cancer, and deaths. England’s National Health Service has made elimination a priority through aggressive testing, treatment expansion, and negotiated drug pricing, serving as a model for what is possible. The stakes are high: hepatitis C affects an estimated 2.4 million Americans, many unaware of their infection, and is a leading cause of liver transplants. The full version stays on the original page, which this listing opens directly.